A word from our Head of Quality and Regulatory Affairs
Our quality commitment to you
At our facility, we are committed to producing the highest quality NAD+ using a state‑of‑the‑art manufacturing processes. Production takes place in a rigorously validated cleanroom environment with double filtration air systems to ensure outstanding purity and cleanliness. We maintain complete traceability at every step and use only carefully qualified raw materials from certified suppliers.
To ensure sterility and safety, all materials used in our production are either sterile upon arrival or undergo validated sterilisation on site. During the filling of each pen, vial or nasal spray with NAD+, we work under advanced laminar flow hoods that maintain an essentially zero‑particle environment. Our NAD+ solution undergoes a dual 0.22 µm filtration process, providing highly effective removal of particulate and biological contaminants before final filling.
Each batch of NAD+ is released only after comprehensive quality control testing, including sterility and purity assessments, supported by independent laboratory analyses where appropriate. Our quality protocols are designed to detect and eliminate any deviations, and are embedded within a broader Quality Management System aligned with GMP and HACCP principles.
As Head of Quality Control and Regulatory Compliance, I oversee the entire process—from supplier qualification and raw material release through in‑process controls and final batch certification—to ensure that every NAD+ pen, vial and nasal spray meets our stringent internal standards as well as all applicable regulatory requirements.